Mild Cognitive Impairment Clinical Trial
Official title:
MIND&GAIT - Promoting Independent Living in Frail Older Adults by Improving Cognition and Gait Ability and Using Assistive Products
A strategy involving 6 partners was planned, targeting the components of education, innovation, and practice-based research with knowledge transfer into clinical practice.The project MIND&GAIT aims to promote independent living in frail older people through the development of innovative initiatives and systems to improve cognition and gait ability. A structured and integrated Combined Intervention (CI) will be developed, composed by: cognitive stimulation program, an animal-assisted therapy program, a physical activity program. Moreover, an auto-blocking mechanism for rolling walkers will be developed and implemented in this study. The results of the study and all the material that was used, will be disseminated in a web platform.
In this growing context of aging societies, the number of institutionalized older adults
tends to increase. Several reasons lead to the institutionalization of older people,
including physical and cognitive decline. In Portugal,in the population aged over 60 years,
there was approximately 160,287 people with dementia, which corresponds to 5.91% of the
people covered by these age groups. Mild cognitive impairment (MCI) is considered as an
intermediate state between normal cognitive ageing and mild dementia, particularly in older
people. It is increasingly recognized as a major health problem associated with an increased
risk for dementia. Cognitive health maintenance is essential for preventing cognitive
impairment and delaying the onset of dementia, dependency, and (in)ability to self-care. In
older people with cognitive decline, cognitive stimulation can be a promising intervention
for reducing depressive symptoms and depressive vulnerability, improving their quality of
life. On the other hand, healthy ageing has traditionally focused on disease prevention, but
greater efforts are needed to reduce frailty and dependency, and maintain independent
physical and cognitive function among older adults. The aging process associated with a
sedentary lifestyle can lead to the decline of some physical capacities. Maintaining
functional status and reducing age-related morbidity is an important part of active ageing
policies; it promotes independent living, improves the quality of life, and reduces health
care costs. In this way exercise programs reduce age-related decline in functional capacity
and maintain muscle strength and mass among adults aged 65-85 years.
The research team intend to intervene in the promotion of active ageing, including physical
exercise and activities that promote the delay and/or maintenance of the cognitive and
physical health of frail older people.
In this way, a randomized controlled trial will be conducted by the research team, composed
by two arms: experimental group (CI group) and control group. The aim of this study is to
assess the impact of the CI program on frail older people. The evaluation of the
effectiveness of the Combined Intervention will have the following methodology:
- Sample Test: For sample size calculation it was used the software G*Power 3.1.9.2. Power
analysis was based on a type I error of 0.05; power of 0.80; effect size f=0.30; and ANOVA:
repeated measures between factors determined a total sample size of 62.Participants with more
than 65 or more years will be recruited from two homes for the aged. Participants will be
randomly distributed in groups of 8, in the control group and in the experimental group.
Participants will be classified as having mild to moderate cognitive decline and risk of fall
from mild to moderate. The control group will receive usual care.
-Intervention: The combined intervention will be implemented over 21 weeks, 4 times a week.
Cognitive Stimulation Program (CSP) will be applied once a week and Physical Activity Program
(PAP) 3 times a week for 30-60 min. Participants using rolling walkers will benefit from the
autoblocking kit mechanism for rolling walkers mechanism (ABMRW) during the execution of the
PAP.
-Data analysis: Statistical analysis will be performed through repeated meaures and ANOVA.
Age, gender, and initial scores of depression and Activities of Daily Living (ADLs) will be
introduced as covariates. Intention-to-treat analysis will be done to analyze the data of the
people who left the study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |